Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Methotrexate vs Triple Intrathecal Therapy in Non–High-Risk Pediatric Acute Lymphoblastic Leukemia
TCTR20190702002Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of methotrexate in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
methotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on TCTR20190702002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190702002.